Company / Profit Margin
Outlook Therapeutics, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-5331.8%
FY2025
5-year range
-5331.8% / -423.8%
FY2021-FY2025
Trend
-1158.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -1158% YoY in FY2025, a notable deviation from the 5-year average annual change of -230%.
Based on SEC 10-K filings.
-5331.8% in FY2025 with a 5-year CAGR of -4908.0%.
Declined from -974.6% to -5331.8% over the past 6 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -4908.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 1158.1% year-over-year.
- Peak profit margin was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -5331.8% | -1158.1% |
| FY2020 | -423.8% | +56.5% |
| FY2019 | -974.6% | +4.4% |
| FY2018 | -1019.3% | +43.0% |
| FY2017 | -1788.9% | -97.0% |
| FY2016 | -908.1% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026